Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate Patent Expiration
Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate is used for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy. It was first introduced by Jazz Pharmaceuticals Ireland Ltd
Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate Patents
Given below is the list of patents protecting Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xywav | US12138233 | Methods of treating idiopathic hypersomnia | Feb 22, 2041 | Jazz |
| Xywav | US12139233 | Electric snowmobile | Feb 22, 2041 | Jazz |
| Xywav | US11426373 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Sep 19, 2037 | Jazz |
| Xywav |
US10213400 (Pediatric) | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Sep 15, 2033 | Jazz |
| Xywav |
US10864181 (Pediatric) | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Sep 15, 2033 | Jazz |
| Xywav |
US11253494 (Pediatric) | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Sep 15, 2033 | Jazz |
| Xywav |
US8772306 (Pediatric) | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Sep 15, 2033 | Jazz |
| Xywav |
US9050302 (Pediatric) | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Sep 15, 2033 | Jazz |
| Xywav |
US9486426 (Pediatric) | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Sep 15, 2033 | Jazz |
| Xywav | US10213400 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Mar 15, 2033 | Jazz |
| Xywav | US10864181 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Mar 15, 2033 | Jazz |
| Xywav | US11253494 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Mar 15, 2033 | Jazz |
| Xywav | US11986446 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Mar 15, 2033 | Jazz |
| Xywav | US8772306 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Mar 15, 2033 | Jazz |
| Xywav | US9050302 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Mar 15, 2033 | Jazz |
| Xywav | US9486426 | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters | Mar 15, 2033 | Jazz |
| Xywav | US10195168 | Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders | Jan 11, 2033 | Jazz |
| Xywav | US10675258 | Method of using gamma-hydroxybutyrate compositions for the treatment of disorders | Jan 11, 2033 | Jazz |
| Xywav | US11554102 | Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders | Jan 11, 2033 | Jazz |
| Xywav | US8591922 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Jan 11, 2033 | Jazz |
| Xywav | US8901173 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Jan 11, 2033 | Jazz |
| Xywav | US9132107 | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | Jan 11, 2033 | Jazz |
| Xywav |
US8731963 (Pediatric) | Sensitive drug distribution system and method |
Jun 17, 2023
(Expired) | Jazz |
| Xywav | US8731963 | Sensitive drug distribution system and method |
Dec 17, 2022
(Expired) | Jazz |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate's patents.
Latest Legal Activities on Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate's Patents
Given below is the list recent legal activities going on the following patents of Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 29 May, 2024 | US10864181 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 24 Apr, 2024 | US9486426 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Nov, 2023 | US10675258 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 01 Mar, 2023 | US9132107 |
| Patent Issue Date Used in PTA Calculation Critical | 17 Jan, 2023 | US11554102 |
| Recordation of Patent Grant Mailed Critical | 17 Jan, 2023 | US11554102 |
| Email Notification Critical | 29 Dec, 2022 | US11554102 |
| Issue Notification Mailed Critical | 28 Dec, 2022 | US11554102 |
| Application Is Considered Ready for Issue Critical | 13 Dec, 2022 | US11554102 |
| Dispatch to FDC | 13 Dec, 2022 | US11554102 |
Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate's Family Patents
